Bellerophon Therapeutics Current Cash

Bellerophon Therapeutics (BLPH) currently reports a current cash of $4.4M as of September 2023. That compares with $11M in the prior-year period — down 61.3% year over year. Use the charts on this page to explore Bellerophon Therapeutics's current cash history and peer comparisons.

Bellerophon Therapeutics's current cash decreased from $11M to $4.4M — a 61.3% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bellerophon Therapeutics reported $4.4M in current cash as of September 2023. That compares with $11M in the prior-year period — down 61.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $4.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bellerophon Therapeutics, and consider following BLPH for alerts when major investors trade the stock.

Bellerophon Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $4.4M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BLPH with unrelated industries.